Global Fidaxomicin Market Insights, Forecast to 2025

This report studies the global market size of Fidaxomicin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fidaxomicin in these regions.
This research report categorizes the global Fidaxomicin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

In 2017, the global Fidaxomicin market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Fidaxomicin market based on company, product type, application and key regions.

The various contributors involved in the value chain of Fidaxomicin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Fidaxomicin include
Astellas
Merck

Market Size Split by Type
Purity:90%
Purity:95%
Others
Market Size Split by Application
Hospital
Retail Pharmacies

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Fidaxomicin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Fidaxomicin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Fidaxomicin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fidaxomicin with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Fidaxomicin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Fidaxomicin are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Fidaxomicin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Fidaxomicin Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Fidaxomicin Market Size Growth Rate by Type
1.4.2 Purity:90%
1.4.3 Purity:95%
1.4.4 Others
1.5 Market by Application
1.5.1 Global Fidaxomicin Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Fidaxomicin Market Size
2.1.1 Global Fidaxomicin Revenue 2016-2025
2.1.2 Global Fidaxomicin Sales 2016-2025
2.2 Fidaxomicin Growth Rate by Regions
2.2.1 Global Fidaxomicin Sales by Regions
2.2.2 Global Fidaxomicin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Fidaxomicin Sales by Manufacturers
3.1.1 Fidaxomicin Sales by Manufacturers
3.1.2 Fidaxomicin Sales Market Share by Manufacturers
3.1.3 Global Fidaxomicin Market Concentration Ratio (CR5 and HHI)
3.2 Fidaxomicin Revenue by Manufacturers
3.2.1 Fidaxomicin Revenue by Manufacturers (2016-2018)
3.2.2 Fidaxomicin Revenue Share by Manufacturers (2016-2018)
3.3 Fidaxomicin Price by Manufacturers
3.4 Fidaxomicin Manufacturing Base Distribution, Product Types
3.4.1 Fidaxomicin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Fidaxomicin Product Category
3.4.3 Date of International Manufacturers Enter into Fidaxomicin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Fidaxomicin Sales by Type
4.2 Global Fidaxomicin Revenue by Type
4.3 Fidaxomicin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Fidaxomicin Breakdown Data by Application

6 North America
6.1 North America Fidaxomicin by Countries
6.1.1 North America Fidaxomicin Sales by Countries
6.1.2 North America Fidaxomicin Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Fidaxomicin by Type
6.3 North America Fidaxomicin by Application
6.4 North America Fidaxomicin by Company

7 Europe
7.1 Europe Fidaxomicin by Countries
7.1.1 Europe Fidaxomicin Sales by Countries
7.1.2 Europe Fidaxomicin Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Fidaxomicin by Type
7.3 Europe Fidaxomicin by Application
7.4 Europe Fidaxomicin by Company

8 Asia Pacific
8.1 Asia Pacific Fidaxomicin by Countries
8.1.1 Asia Pacific Fidaxomicin Sales by Countries
8.1.2 Asia Pacific Fidaxomicin Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Fidaxomicin by Type
8.3 Asia Pacific Fidaxomicin by Application
8.4 Asia Pacific Fidaxomicin by Company

9 Central & South America
9.1 Central & South America Fidaxomicin by Countries
9.1.1 Central & South America Fidaxomicin Sales by Countries
9.1.2 Central & South America Fidaxomicin Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Fidaxomicin by Type
9.3 Central & South America Fidaxomicin by Application
9.4 Central & South America Fidaxomicin by Company

10 Middle East and Africa
10.1 Middle East and Africa Fidaxomicin by Countries
10.1.1 Middle East and Africa Fidaxomicin Sales by Countries
10.1.2 Middle East and Africa Fidaxomicin Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Fidaxomicin by Type
10.3 Middle East and Africa Fidaxomicin by Application
10.4 Middle East and Africa Fidaxomicin by Company

11 Company Profiles
11.1 Astellas
11.1.1 Astellas Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Fidaxomicin
11.1.4 Fidaxomicin Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Fidaxomicin
11.2.4 Fidaxomicin Product Description
11.2.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Fidaxomicin Raw Material
13.1.2 Fidaxomicin Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Fidaxomicin
Figure Global Fidaxomicin Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Fidaxomicin Production Market Share by Types (Product Category) in 2017
Figure Purity:90% Product Picture
Table Major Manufacturers of Purity:90%
Figure Purity:95% Product Picture
Table Major Manufacturers of Purity:95%
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Fidaxomicin Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital
Figure Retail Pharmacies
Figure Fidaxomicin Report Years Considered
Figure Global Fidaxomicin Market Size 2016-2025 (Million US$)
Figure Global Fidaxomicin Sales 2016-2025 (K Units)
Table Global Fidaxomicin Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Fidaxomicin Sales by Regions 2016-2025 (K Units)
Table Global Fidaxomicin Sales Market Share by Regions 2016-2025
Figure Global Fidaxomicin Sales Market Share by Regions 2016-2025
Figure 2017 Global Fidaxomicin Sales Market Share by Regions
Table Global Fidaxomicin Revenue by Regions 2016-2025 (Million US$)
Table Global Fidaxomicin Revenue Market Share by Regions 2016-2025
Figure Global Fidaxomicin Revenue Market Share by Regions 2016-2025
Figure 2017 Global Fidaxomicin Revenue Market Share by Regions
Table Global Fidaxomicin Sales by Manufacturers (2016-2018) (K Units)
Table Global Fidaxomicin Sales Share by Manufacturers (2016-2018)
Figure Global Fidaxomicin Sales Share by Manufacturers in 2017
Table Fidaxomicin Revenue by Manufacturers (2016-2018) (Million US$)
Table Fidaxomicin Revenue Share by Manufacturers (2016-2018)
Figure Fidaxomicin Value Share by Manufacturers in 2017
Table Global Fidaxomicin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Fidaxomicin Price (2016-2018) (USD/Unit)
Table Fidaxomicin Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Fidaxomicin Product Category
Table Date of International Manufacturers Enter into Fidaxomicin Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Fidaxomicin Sales by Type (2016-2025) (K Units)
Table Global Fidaxomicin Sales Share by Type (2016-2025)
Figure Global Fidaxomicin Sales Market Share by Type (2016-2025)
Figure Global Fidaxomicin Sales Market Share by Type in 2017
Table Global Fidaxomicin Revenue by Type (2016-2025) (Million US$)
Table Global Fidaxomicin Revenue Share by Type (2016-2025)
Figure Global Fidaxomicin Revenue Market Share by Type (2016-2025)
Figure Global Fidaxomicin Revenue Market Share by Type in 2017
Table Fidaxomicin Price by Type 2013-2018 (USD/Unit)
Table Global Fidaxomicin Sales by Application (2016-2025) (K Units)
Table Global Fidaxomicin Sales Share by Application (2016-2025)
Figure Global Sales Fidaxomicin Market Share by Application (2016-2025)
Figure Global Sales Fidaxomicin Market Share by Application (2016-2025)
Figure North America Fidaxomicin Sales Growth Rate 2016-2025 (K Units)
Figure North America Fidaxomicin Revenue Growth Rate 2016-2025 (Million US$)
Table North America Fidaxomicin Sales by Countries (2016-2025) (K Units)
Table North America Fidaxomicin Sales Market Share by Countries (2016-2025)
Figure 2017 North America Fidaxomicin Sales Market Share by Countries
Table North America Fidaxomicin Revenue by Countries (2016-2025) (Million US$)
Table North America Fidaxomicin Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Fidaxomicin Revenue Market Share by Countries
Figure United States Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure United States Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Canada Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Table North America Fidaxomicin Sales by Type (2016-2025) (K Units)
Table North America Fidaxomicin Sales Market Share by Type (2016-2025)
Figure 2017 North America Fidaxomicin Market Share by Type
Table North America Fidaxomicin Sales by Application (2016-2025) (K Units)
Table North America Fidaxomicin Sales Market Share by Application (2016-2025)
Figure 2017 North America Fidaxomicin Market Share by Application
Table North America Fidaxomicin Sales by Company (2016-2018) (K Units)
Table North America Fidaxomicin Sales Market Share by Company (2016-2018)
Figure North America Fidaxomicin Sales Market Share by Company in 2017
Figure Europe Fidaxomicin Sales Growth Rate 2016-2025 (K Units)
Figure Europe Fidaxomicin Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Fidaxomicin Sales by Countries (2016-2025) (K Units)
Table Europe Fidaxomicin Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Fidaxomicin Sales Market Share by Countries
Table Europe Fidaxomicin Revenue by Countries (2016-2025) (Million US$)
Table Europe Fidaxomicin Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Fidaxomicin Revenue Market Share by Countries
Figure Germany Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Germany Fidaxomicin Revenue Growth Rate (2016-2025) (K Units)
Figure France Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure France Fidaxomicin Revenue Growth Rate (2016-2025) (K Units)
Figure UK Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure UK Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Italy Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Russia Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Fidaxomicin Sales by Type (2016-2025) (K Units)
Table Europe Fidaxomicin Sales Market Share by Type (2016-2025)
Figure 2017 Europe Fidaxomicin Market Share by Type
Table Europe Fidaxomicin Sales by Application (2016-2025) (K Units)
Table Europe Fidaxomicin Sales Market Share by Application (2016-2025)
Figure 2017 Europe Fidaxomicin Market Share by Application
Table Europe Fidaxomicin Sales by Company (2016-2018) (K Units)
Table Europe Fidaxomicin Sales Market Share by Company (2016-2018)
Figure Europe Fidaxomicin Sales Market Share by Company in 2017
Figure Asia Pacific Fidaxomicin Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Fidaxomicin Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Fidaxomicin Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Fidaxomicin Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Fidaxomicin Sales Market Share by Countries
Table Asia Pacific Fidaxomicin Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Fidaxomicin Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Fidaxomicin Revenue Market Share by Countries
Figure China Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure China Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Japan Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Korea Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure India Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure India Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Australia Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Fidaxomicin Sales by Type (2016-2025) (K Units)
Table Asia Pacific Fidaxomicin Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Fidaxomicin Market Share by Type
Table Asia Pacific Fidaxomicin Sales by Application (2016-2025) (K Units)
Table Asia Pacific Fidaxomicin Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Fidaxomicin Market Share by Application
Table Asia Pacific Fidaxomicin Sales by Company (2016-2018) (K Units)
Table Asia Pacific Fidaxomicin Sales Market Share by Company (2016-2018)
Figure Asia Pacific Fidaxomicin Sales Market Share by Company in 2017
Figure Central & South America Fidaxomicin Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Fidaxomicin Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Fidaxomicin Sales by Countries (2016-2025) (K Units)
Table Central & South America Fidaxomicin Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Fidaxomicin Sales Market Share by Countries
Table Central & South America Fidaxomicin Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Fidaxomicin Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Fidaxomicin Revenue Market Share by Countries
Figure Brazil Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Fidaxomicin Sales by Type (2016-2025) (K Units)
Table Central & South America Fidaxomicin Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Fidaxomicin Market Share by Type
Table Central & South America Fidaxomicin Sales by Application (2016-2025) (K Units)
Table Central & South America Fidaxomicin Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Fidaxomicin Market Share by Application
Table Central & South America Fidaxomicin Sales by Company (2016-2018) (K Units)
Table Central & South America Fidaxomicin Sales Market Share by Company (2016-2018)
Figure Central & South America Fidaxomicin Sales Market Share by Company in 2017
Figure Middle East and Africa Fidaxomicin Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Fidaxomicin Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Fidaxomicin Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Fidaxomicin Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Fidaxomicin Sales Market Share by Countries
Table Middle East and Africa Fidaxomicin Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Fidaxomicin Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Fidaxomicin Revenue Market Share by Countries
Figure GCC Countries Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Fidaxomicin Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Fidaxomicin Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Fidaxomicin Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Fidaxomicin Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Fidaxomicin Market Share by Type
Table Middle East and Africa Fidaxomicin Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Fidaxomicin Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Fidaxomicin Market Share by Application
Table Middle East and Africa Fidaxomicin Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Fidaxomicin Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Fidaxomicin Sales Market Share by Company in 2017
Table Astellas Company Details
Table Astellas Fidaxomicin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Astellas Recent Development
Table Merck Company Details
Table Merck Fidaxomicin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Fidaxomicin Value Chain
Table Typical Suppliers of Key Fidaxomicin Raw Material
Table Fidaxomicin Customers List
Table Fidaxomicin Sales Channels
Table Fidaxomicin Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Enquiryform

Purchase